Did You Know...
...that Thomas Edison's patent application on his phonograph was approved by the Patent Office in just seven weeks? In contrast, it took Gordon Gould, the inventor of the laser, 30 years to obtain his patent -- finally awarded in 1988!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120004194 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES Novel aldehyde-functionalized polysaccharide compositions are described that are more stable in aqueous solution than oxidized polysaccharides or other types of polysaccharides containing pendant aldehyde groups. The aldehyde-functionalized polysaccharides may be reacte... | 01/05/2012 |
| 20110269701 | 7,2''-DEHYDRATE PUERARIN AND ITS SALTS, PREPARATION METHOD AND USE THEREOF A 7,2″-dehydrate puerarin represented by formula (I) and salt derivatives thereof. The compounds are prepared from puerarin by intramolecular mitsunobu reaction. They are capable of shortening arrhythmia duration and prolonging coagulation time. They can be prepared i... | 11/03/2011 |
| 20110237789 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES The present invention relates to processes for preparing a glucopyranosyl-substituted benzyl-benzene derivative of general formula III, wherein R1 is defined according to claim 1. ... | 09/29/2011 |
| 20110237526 | METHOD FOR THE PREPARATION OF A CRYSTALLINE FORM The invention relates to a method for the preparation for a crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene. In addition the invention relates to a crystalline form obtainable by this method, to a pharmaceutical... | 09/29/2011 |
| 20110229550 | Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials Compositions and methods of making a modified polyhydroxylated polymer comprising a polyhydroxylated polymer having reversibly modified hydroxyl groups, whereby the hydroxyl groups are modified by an acid-catalyzed reaction between a polydroxylated polymer and a reagent... | 09/22/2011 |
| 20110230403 | GLYCOSIDE DERIVATIVES AND USES THEREOF The present invention relates to compounds of formula I and pharmaceutically acceptable salts, to formulations and uses of the compounds of formula (I) in the treatment of metabolic disorders.... | 09/22/2011 |
| 20110201795 | Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors Method for the production of C-aryl glucoside SGLT2 inhibitors useful for the treatment of diabetes and related diseases. and intermediates thereof. The C-aryl glucosides may be complexed with amino acid complex forming reagents.... | 08/18/2011 |
| 20110152513 | CONVERSION OF CARBOHYDRATES TO HYDROCARBONS Materials and processes for the conversion of carbohydrates and polyols to gasoline boiling range hydrocarbons. Carbohydrates and polyols are reacted in the presence of modified zeolite catalysts to form a reaction product containing non-aromatic and aromatic gasoline b... | 06/23/2011 |
| 20110144317 | MUTANTS OF GLYCOSIDE HYDROLASES AND USES THEREOF FOR SYNTHESIZING COMPLEX OLIGOSACCHARIDES AND DISACCHARIDE INTERMEDIATES Method for preparing the disaccharide [α-D-Gldp(1→3)]-α-L-Rhap-YR wherein Y is selected from —O— and —S— and R is selected from the group consisting of: C1-C6 alkyl, C1-C6 alkenyl, aryl, allyl, —CO-alkyl (C1... | 06/16/2011 |
| 20110144053 | Process for Obtaining Purified Pterostilbene and Methods of Use Thereof The present invention relates to a process of extraction and purification of a stilbenoid, pterostilbene, from botanical sources. The process involves obtaining pterostilbene having high degree of purity and the present invention also relates to pure form of pterostilbe... | 06/16/2011 |
| 20110112039 | Polysaccharides comprising carboxyl functional groups substituted via esterification by a hydrophobic alcohol Polysaccharide including carboxyl functional groups. The polysaccharide being chosen from the group of anionic synthetic polysaccharides including 1,6 bonds obtained from neutral polysaccharides of which at least one of a carboxyl functional groups is esterified by a hy... | 05/12/2011 |
| 20110034402 | C-ARYL GLYCOSIDE COMPOUNDS FOR THE TREATMENT OF DIABETES AND OBESITY This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixtu... | 02/10/2011 |
| 20110028414 | GLUCOPYRANOSIDE DERIVATIVES Novel compounds of the formula (I), in which X has the meaning indicated in Patent Claim 1, are suitable as antidiabetics.... | 02/03/2011 |
| 20110024292 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, includin... | 02/03/2011 |
| 20110014284 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.... | 01/20/2011 |
| 20100322958 | MODIFIED SACCHARIDES Modified capsular saccharides comprising a blocking group at a hydroxyl group position on at least one of the monosaccharide units of the corresponding native capsular saccharide, wherein the blocking group is of the formula (Ia) or (Ib): —OX—Y (Ia) or —O—R... | 12/23/2010 |
| 20100317820 | Polyol Functionalized Water Soluble Carbon Nanostructures A method of making a water soluble carbon nanostructure includes treating a fluorinated carbon nanostructure material with a polyol in the presence of a base. A water soluble carbon nanostructure comprises a fluorinated carbon nanostructure covalently bound to a polyol.... | 12/16/2010 |
| 20100298550 | PROCESS FOR PRODUCTION OF RIBOFURANOSE DERIVATIVES It is an object of the present invention to provide a process for producing 1,2,3-tri-O-acetyl-5-deoxy-ribofuranose in an industrially appropriate manner. The present invention provides a process for producing a 1,2,3-tri-O-acetyl-5-deoxy-ribofuranose which comprises hy... | 11/25/2010 |
| 20100291639 | Chemical cavitation and cleaning process Cavitation is an often used mechanism for accelerating chemical reactions and for cleaning purposes. This invention describes a very simple process for generating cavitation with a vibration table through vertical excitations which generates a “water hammer” that ge... | 11/18/2010 |
| 20100190969 | NON-NATURALLY OCCURRING CARBOHYDRATE-BASED FIBROUS ELEMENTS AND METHODS FOR MAKING SAME Non-naturally occurring carbohydrate-based fibrous elements and more particularly, non-naturally occurring carbohydrate-based fibrous elements having a macrostructure and a microstructure wherein the microstructure is visible when wet and methods for making same are pro... | 07/29/2010 |
| 20100183635 | GLYCOSYLATED SPECIFICITY EXCHANGERS The present invention is directed to ligand/receptor and antigen/antibody specificity exchangers comprising a saccharide or glycoconjugate. Methods of making these specificity exchangers and methods of using said specificity exchangers to treat or prevent human disease ... | 07/22/2010 |
| 20100184710 | Therapeutic Bifunctional Compounds The invention generally relates to systems and methods for treating inflammatory and proliferative diseases, enabling treatment of MDR tumor cells by using a bifunctional compound that inhibits both fatty acid metabolism and glycolysis. Thus, the invention links a fatty... | 07/22/2010 |
| 20100174001 | ANTIOXIDANT FOR FOOD The present invention relates to the technical field of additives or adjuncts, especially additives that have an antioxidant effect and antioxidants, for food products, animal feed, cosmetics, and pharmaceuticals. The present invention above all provides an improved ant... | 07/08/2010 |
| 20100167988 | ETHOXYPHENYLMETHYL INHIBITORS OF SGLT2 The present invention relates to new ethoxyphenylmethyl modulators of SGLT2, pharmaceutical compositions thereof, and methods of use thereof. ... | 07/01/2010 |
| 20100163484 | Compound for denitrifying wastewater Disclosed is a method of denitrifying a solution including introducing into the solution an amount of a carbon source within a duration and at a frequency so that indigenous heterotrophic bacteria deplete dissolved oxygen in the solution and decompose oxygen from nitrat... | 07/01/2010 |
| 20100144651 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE The present invention relates to novel glucofuranose esters and glucopyranose esters of alkyl-fumarates. The esters are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.... | 06/10/2010 |
| 20100113731 | SUGAR-ALCOHOL-MODIFIED ORGANOPOLYSILOXANE COMPOUND AND PROCESSES FOR PRODUCING THE SAME An object of the invention is to provide a novel sugar-alcohol-modified organopolysiloxane compound which can have hydrophilicity effectively imparted thereto with a raw material incorporated even in a smaller amount, by using a precursor having a sugar alcohol residue,... | 05/06/2010 |
| 20100093663 | Sulfoalkyl Ether Cyclodextrin Compositions SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a w... | 04/15/2010 |
| 20090326215 | GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R1 to R6 as well as R7a, R7b, R7c are defined herein and the tautome... | 12/31/2009 |
| 20090312281 | PROCESS FOR THE PREPARATION OF A PULVERULENT COMPOSITION AND PRODUCT AS OBTAINED Method of preparing a non-hygroscopic pulverulent composition, includes a step for the spray drying, without an atomization support, of an aqueous solution containing at least one initially hygroscopic product, having a glass transition temperature ranging from 10° C. ... | 12/17/2009 |
| 20090118201 | BENZYLBENZENE DERIVATIVES AND METHODS OF USE Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or ... | 05/07/2009 |
| 20090023913 | GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R1 to R6 as well as R7a, R7b, R7c are defined herein and the tautome... | 01/22/2009 |
| 20080292775 | Delivery Systems for Natural High-Potency Sweetener Compositions, Methods for Their Formulation, and Uses The present invention provides substantially water soluble, substantially non-dusting delivery systems for natural high-potency sweeteners, methods for their formulation, and uses. In particular, the present invention relates to different delivery systems of sweetener c... | 11/27/2008 |
| 20080193568 | Polyacetylenic Compounds This invention relates to a method of treating type II diabetes with a polyacetylenic compound of the following formula: in which R1 is H, C1-C10 alkyl, C2-C10... | 08/14/2008 |
| 20070015717 | 4-[(E)-2-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPTHALENYL)-1-PROPENYL]BENZOIC ACID ANALOGS AND METHOD OF MANUFACTURE AND USE THEREOF Analogs of 4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid and methods of manufacture and use thereof, such as for use in cancer prevention and treatment. ... | 01/18/2007 |
| 20060287255 | C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth Compounds of the formula: are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans. ... | 12/21/2006 |
| 20060100423 | Process for the preparation and separation of arabinose and xylose from a mixture of saccharides A process for the preparation and separation of the pentoses, xylose and arabinose from mixtures of saccharides by forming acetals is described. D-xylose is a precursor to xylitol, a sweetener, and L-arabinose is a precursor to the drug intermediate (R)-3,4-dihydroxybut... | 05/11/2006 |
| 20060088491 | Novel polyol-glycoside compositions for the skin The invention concerns novel polyol-glycoside compositions for topical use. The invention is characterized in that said compositions contain an efficient amount of polyol-glycoside obtained by acetalization of a polyol of formula (I), wherein n is an integer equal to 2... | 04/27/2006 |
| 20060074031 | D-pyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture D-pyranosyl-substituted phenyls of general formula I wherein the groups R1 to R5, X, Z and R7a, R7b, R7c are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransp... | 04/06/2006 |
| 20050277599 | Pentose derivatives as anti-hyperglycemic drugs The present invention relates to pentose and pentose derivatives that are effective at increasing glucose transport in a non-insulin dependent manner, and to uses thereof for a) treating and/or preventing hyperglycemia; b) treating and/or preventing the complications of... | 12/15/2005 |
